Katy Palmer Joins KJT as Strategic Accounts, SVP

Katy Palmer Joins KJT as Strategic Accounts, SVP

We are delighted to welcome Katy Palmer, PhD as our new Strategic Accounts, SVP, at KJT. With a rich background in executive leadership and over two decades of experience in life science commercial insights, Katy brings a unique blend of strategic thinking, business acumen, and scientific expertise to our team. Having demonstrated remarkable leadership skills in business development and fostering cohesive work environments, Katy’s people-first approach will undoubtedly elevate our team.

With a profound commitment to client satisfaction, Katy will spearhead our Strategic Account Team, ensuring that our clients, both existing and prospective, benefit from the true essence of collaboration and excellence that defines KJT. Her deep-rooted passion for medical innovation, backed by a comprehensive understanding of research methodologies and customer-centric principles, will steer us towards greater success in the healthcare insights industry.

Katy earned her doctorate in immunology and infectious disease from Washington University in St. Louis and her BA in Biology from Lake Forest College, solidifying her academic prowess in the field. We look forward to the impactful contributions she will make to our organization.

“We are thrilled to have Katy join the Leadership Team at KJT given her decades of experience supporting pharmaceutical brands. Her scientific background coupled with research expertise is an exceptional match for our team and we look forward to our employees and clients benefitting from working with her. In these early days, she has already demonstrated a strong command of our clients’ business challenges and how KJT solutions can afford them more confidence in their business decisions,” said Michaela Gascon, President and CEO of KJT.

Blogs & News

Read More
Read More

Unlocking Participant Engagement: The Key to Meaningful Market Research

In pharmaceutical market research, one element remains consistently crucial: participant…

Read More
Read More

Navigating Successful Real-World Evidence Publications: An Interdisciplinary Journey

Publishing real-world evidence (RWE) research involves a comprehensive journey of strategic…

Read More
Read More

Go from Exam Room Conversations to Actionable Healthcare Insights

Understanding what goes on in the exam room between patients and HCPs remains a critical yet…

Read More
Read More

Patient Voice Isn’t Optional, It’s the Future of RWE

Real-world evidence (RWE) is only as meaningful as the perspectives it includes. While healthcare…

Read More
Read More

4 Use Cases for Augmenting Primary Data with Synthetic Data in Pharma Market Research

Synthetic data is not new to market research, and the healthcare insights industry is starting to…

Read More
Read More

Beyond the Hype: How Digital Twins Are Transforming Market Research

Digital twins are reshaping the way we generate insights across industries. In this webinar, we…

Read More
Read More

5 Takeaways from an Intellus Newbie

Having spent 25 years in the consumer research sector (finance, CPG, retail, tech, etc), I am used…

Read More
Read More

Reflections on PMRC 2025: The AI Train Left the Station… “Next Stop”

I have attended more than half of the PMRC conferences held over the past 16 years. Being a veteran…

Read More
Read More

10 Best Practices in Conducting Ethnography in Rare Disease Population

Rare disease patients face unique challenges that are often overlooked or misunderstood by those…

Read More
Read More

Building the Future: Why Qualitative Insights Will Thrive in the Age of AI

AI is transforming the way we collect and analyze qualitative data—but rather than replacing…

Let’s Take Research Further. Together.